• OTLK Stock Soars 28% After FDA Sets July Date For Lytenava Decision Stocktwits Fri, 10 Jul 2026 07:44:48 GMT
• Outlook Therapeutics Regains Nasdaq Compliance as FDA Schedules ONS-5010 Verdict for July AD HOC NEWS Fri, 10 Jul 2026 01:12:44 GMT
• fda fast-track fuels outlook therapeutics rally, though sparse volume gives pause AD HOC NEWS Thu, 09 Jul 2026 14:25:17 GMT
• outlook therapeutics prepares for a pivotal july: shareholder vote and fda decision loom over a stoc Ad-hoc-news.de Thu, 09 Jul 2026 04:06:57 GMT
• OTLK Stock Holds Nasdaq Compliance As FDA Clock Starts StocksToTrade Wed, 08 Jul 2026 16:33:00 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision Stocktwits Sun, 05 Jul 2026 20:31:44 GMT
• Outlook Therapeutics(OTLK) Stock Options Chain | Quotes & News Moomoo Sun, 05 Jul 2026 02:54:19 GMT
• outlook therapeutics files dispute resolution request with fda Investing.com Sat, 04 Jul 2026 20:58:35 GMT
• Enterprise value to revenue forward of Outlook Therapeutics, Inc. – NASDAQ:OTLK TradingView Sat, 04 Jul 2026 11:46:53 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision Stocktwits Fri, 03 Jul 2026 11:41:10 GMT
• Outlook Therapeutics Stock (OTLK) Opinions on FDA Review for Lytenava Quiver Quantitative Wed, 01 Jul 2026 17:57:00 GMT
• outlook therapeutics' july of dual verdicts: from shareholder vote to fda decision AD HOC NEWS Tue, 30 Jun 2026 05:05:21 GMT
• with $7.7 million in the bank, outlook therapeutics bets everything on a july fda ruling AD HOC NEWS Mon, 29 Jun 2026 15:07:34 GMT
• short sellers circle outlook therapeutics at record pace as fda verdict looms AD HOC NEWS Mon, 29 Jun 2026 02:11:59 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision Stocktwits Sat, 27 Jun 2026 13:07:56 GMT
• Outlook Therapeutics Regains Nasdaq Minimum Bid Compliance The Globe and Mail Sat, 27 Jun 2026 07:00:00 GMT
• outlook therapeutics (otlk) regains compliance with nasdaq minimum bid price requirement – 8-k filing june 2026 – minichart Minichart Sat, 27 Jun 2026 00:56:00 GMT
• Outlook Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard TradingView Fri, 26 Jun 2026 21:33:00 GMT
• enterprise value to ebitda forward of outlook therapeutics, inc. – nasdaq:otlk TradingView Fri, 26 Jun 2026 13:34:55 GMT
• outlook therapeutics, inc. actuals & estimates (nasdaq:otlk) TradingView Fri, 26 Jun 2026 09:39:21 GMT
• Outlook Therapeutics (OTLK) restores Nasdaq minimum bid compliance, delisting threat closed Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• otlk stock climbs as fda fast-tracks lytenava decision StocksToTrade Fri, 26 Jun 2026 07:00:00 GMT
• outlook therapeutics, inc. actuals & estimates (fwb:41o) TradingView Fri, 26 Jun 2026 05:03:58 GMT
• enterprise value to revenue forward of outlook therapeutics, inc. – mun:41o TradingView Thu, 25 Jun 2026 18:01:08 GMT
• price to sales forward of outlook therapeutics, inc. – nasdaq:otlk TradingView Thu, 25 Jun 2026 15:46:51 GMT
• outlook therapeutics(otlk) stock options chain | quotes & news Moomoo Wed, 24 Jun 2026 12:47:19 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision Stocktwits Wed, 24 Jun 2026 11:30:29 GMT
• otlk stock surges on fda lytenava application resubmission after successful appeal Stocktwits Tue, 23 Jun 2026 19:32:28 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision MSN Mon, 22 Jun 2026 06:50:23 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision Stocktwits Sun, 21 Jun 2026 06:56:10 GMT
• outlook therapeutics(otlk) stock options chain | quotes & news Moomoo Sun, 21 Jun 2026 05:25:49 GMT
• outlook therapeutics faces a pivotal july: dilution vote, european rollout, and an fda verdict in th AD HOC NEWS Fri, 19 Jun 2026 15:56:59 GMT
• outlook therapeutics rides two waves: european lytenava rollout and fda clock ticking toward july 29 AD HOC NEWS Fri, 19 Jun 2026 15:56:59 GMT
• outlook therapeutics stock - weekly review and sector context for biotech eye drug maker AD HOC NEWS Fri, 19 Jun 2026 14:35:16 GMT
• otlk stock up 35% as fda accepts resubmitted eye drug bla for review MSN Fri, 19 Jun 2026 10:49:41 GMT
• outlook therapeutics inc (otlk) shareholder structure: major shareholders & institutional holdings TradingKey Fri, 19 Jun 2026 05:59:50 GMT
• outlook therapeutics' high-risk bet: one fda ruling and a 568% rally in the balance AD HOC NEWS Fri, 19 Jun 2026 04:04:10 GMT
• high-stakes gamble: outlook therapeutics pins its fate on a single fda verdict AD HOC NEWS Fri, 19 Jun 2026 03:46:58 GMT
• one month, one drug, one verdict: outlook therapeutics' lytenava awaits fda's answer on july 29 AD HOC NEWS Fri, 19 Jun 2026 00:02:34 GMT
• outlook therapeutics secures fda class-1 review for lytenava, yet cash crunch and european slowdown AD HOC NEWS Thu, 18 Jun 2026 15:01:44 GMT
• outlook therapeutics’ lytenava nears fda verdict as shares skyrocket — but rsi flashes caution AD HOC NEWS Thu, 18 Jun 2026 14:47:03 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision Stocktwits Thu, 18 Jun 2026 09:36:01 GMT
• Outlook Therapeutics Heads Into Another FDA PDUFA Decision For Lytenava (NASDAQ:OTLK) Seeking Alpha Thu, 18 Jun 2026 07:00:00 GMT
• outlook therapeutics balances fda opportunity against dilution risk as key dates loom AD HOC NEWS Thu, 18 Jun 2026 04:33:20 GMT
• outlook therapeutics sees 615% surge as fda fast-tracks eye drug review and nasdaq threat fades AD HOC NEWS Wed, 17 Jun 2026 23:02:30 GMT
• outlook therapeutics inc (otlk) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:52:23 GMT
• outlook therapeutics inc (otlk) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:50:09 GMT
• FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA) Ophthalmology Times Europe Wed, 17 Jun 2026 07:00:00 GMT
• FDA accepts resubmitted BLA from Outlook Therapeutics The Pharma Letter Wed, 17 Jun 2026 07:00:00 GMT
• OTLK Stock Up 35% as FDA Accepts Resubmitted Eye Drug BLA for Review Yahoo Finance Wed, 17 Jun 2026 07:00:00 GMT
• Outlook Therapeutics Eye Drug Review Returns To FDA — Again - Outlook Therapeutics (NASDAQ:OTLK) Benzinga Wed, 17 Jun 2026 07:00:00 GMT
• with 560% rally and shorts circling, outlook therapeutics faces make-or-break fda call on july 29 AD HOC NEWS Wed, 17 Jun 2026 05:15:17 GMT
• outlook therapeutics (otlk) gains fda acknowledgment for bla res GuruFocus Wed, 17 Jun 2026 00:56:15 GMT
• outlook therapeutics’ ons-5010/lytenava™ bla accepted by fda for wet amd with july 2026 pdufa date 1 Minichart Tue, 16 Jun 2026 14:33:00 GMT
• fda sets goal date for ophthalmic version of bevacizumab Managed Healthcare Executive Tue, 16 Jun 2026 13:39:47 GMT
• Outlook Therapeutics (OTLK) Stock After FDA Review Win Is The Valuation Case Already Priced In Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• Wet AMD eye drug LYTENAVA enters FDA review before July 29 action date Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• FDA sets July 29, 2026 PDUFA date for Outlook Therapeutics (OTLK) ONS-5010 BLA Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics Shares Surge After FDA Accepts Resubmitted Wet AMD Application marketscreener.com Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics (OTLK) Is Up 60.7% After FDA Class 1 Review Acceptance For Lytenava simplywall.st Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics stock surges on FDA BLA resubmission Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• FDA accepts Outlook Therapeutics’ resubmitted drug application Investing.com Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics (OTLK) Gains After FDA Reconsiders ONS-5010 Application GuruFocus Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics (OTLK) Gains FDA Acknowledgment for BLA Res GuruFocus Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics Stock Jumps as FDA Accepts Lytenava BLA, July Decision Looms TechStock² Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics: FDA accepts resubmitted BLA for ONS-5010 with PDUFA date July 29, 2026 TradingView Tue, 16 Jun 2026 07:00:00 GMT
• Outlook Therapeutics' BLA Resubmission For ONS-5010 Accepted By FDA For Wet AMD Review RTTNews Tue, 16 Jun 2026 07:00:00 GMT
• otlk stock soars 28% after fda sets july date for lytenava decision Stocktwits Tue, 16 Jun 2026 07:00:00 GMT
• outlook therapeutics announces fda acceptance of resubmitted biologics license application for ons-5010/lytenava™ (bevacizumab-vik... Sahm Tue, 16 Jun 2026 07:00:00 GMT
• outlook wet amd therapy regains fda review (otlk:nasdaq) Seeking Alpha Tue, 16 Jun 2026 07:00:00 GMT
• outlook therapeutics’ resubmitted ophthalmic bevacizumab bla accepted for review by fda Pearce IP Tue, 16 Jun 2026 07:00:00 GMT
• outlook therapeutics faces a summer of reckoning: fda, nasdaq, and dilution AD HOC NEWS Tue, 16 Jun 2026 03:33:52 GMT
• Why Outlook Therapeutics (OTLK) Is Up 57.1% After FDA Validates LYTENAVA Efficacy and BLA Resubmission Yahoo Finance Sun, 14 Jun 2026 07:00:00 GMT
• Outlook Therapeutics Surges As FDA Fast-Tracks ONS-5010 Review timothysykes.com Sun, 14 Jun 2026 07:00:00 GMT
• OTLK Jumps As Outlook Therapeutics Wins FDA Backing On BLA Resubmission timothysykes.com Sat, 13 Jun 2026 07:00:00 GMT
• otlk stock jumps as fda fast-tracks lytenava decision timothysykes.com Fri, 12 Jun 2026 15:32:00 GMT
• Outlook Therapeutics (OTLK) Stock After FDA Class 1 BLA Resubmission Is The Valuation Out Of Line simplywall.st Fri, 12 Jun 2026 07:00:00 GMT
• otlk stock jumps as fda fast-tracks lytenava resubmission StocksToTrade Fri, 12 Jun 2026 07:00:00 GMT
• otlk stock jumps as fda fast-tracks lytenava review timothysykes.com Fri, 12 Jun 2026 07:00:00 GMT
• otlk maintained by ascendiant capital -- price target raised to $10.00 GuruFocus Thu, 11 Jun 2026 12:00:00 GMT
• outlook therapeutics (otlk) latest announcement & press release Moomoo Wed, 10 Jun 2026 17:38:04 GMT
• Outlook Therapeutics Gains as FDA Timeline for Lytenava Comes Up TechStock² Wed, 10 Jun 2026 07:00:00 GMT
• otlk stock surges over 50% pre-market, breaches key technical milestone – what’s behind this massive rally? MSN Mon, 08 Jun 2026 11:15:16 GMT
• otlk stock surges over 50% pre-market, breaches key technical milestone – what’s behind this massive rally? MSN Sun, 07 Jun 2026 06:58:47 GMT
• outlook therapeutics gains on fda appeal win, boosting chances for lytenava approval. Pluang Sat, 06 Jun 2026 13:30:21 GMT
• Outlook Therapeutics: Potential Catalysts Offering An Arbitrage Opportunity (NASDAQ:OTLK) Seeking Alpha Sat, 06 Jun 2026 07:00:00 GMT
• outlook therapeutics director haddadin yezan munther buys $24,145 in shares Investing.com Thu, 04 Jun 2026 00:10:46 GMT
• Director at Outlook Therapeutics (NASDAQ: OTLK) buys 29,000 shares Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• outlook therapeutics director haddadin yezan munther buys $24,145 in shares Investing.com Wed, 03 Jun 2026 07:00:00 GMT
• outlook therapeutics resubmits fda application for ons-5010 The Globe and Mail Tue, 02 Jun 2026 14:48:00 GMT
• otlk stock rocket nearly 140%: fda's lytenava approval pushes stock on track for best week on record MSN Tue, 02 Jun 2026 14:04:09 GMT
• outlook eyes rapid fda approval for ophthalmic bevacizumab with refiled bla Citeline News & Insights Tue, 02 Jun 2026 11:58:00 GMT
• outlook therapeutics director’s firm buys $5m in common stock by investing.com Investing.com South Africa Tue, 02 Jun 2026 07:00:00 GMT
• $outlook therapeutics (otlk.us)$ looking forward to seeing what you can do tonight. Moomoo Tue, 02 Jun 2026 05:58:08 GMT
• gms ventures lifts outlook therapeutics (otlk) stake in $5m share deal Stock Titan Tue, 02 Jun 2026 01:36:28 GMT
• [schedule 13d/a] outlook therapeutics, inc. amended major shareholder report Stock Titan Tue, 02 Jun 2026 01:36:27 GMT
• outlook therapeutics (otlk) resubmits biologics license applicat GuruFocus Mon, 01 Jun 2026 14:50:09 GMT
• Outlook Therapeutics resubmits BLA for bevacizumab-vikg (ONS-5010/LYTENAVA) Ophthalmology Times Europe Mon, 01 Jun 2026 07:00:00 GMT
• Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering VisionMonday.com Mon, 01 Jun 2026 07:00:00 GMT
• Outlook Therapeutics (Nasdaq: OTLK) resubmits FDA BLA with 60-day review Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• [SCHEDULE 13D/A] Outlook Therapeutics, Inc. Amended Major Shareholder Report Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Outlook Therapeutics (NASDAQ: OTLK) seeks approval for reverse split and major share increase Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Outlook Therapeutics resubmits drug application to FDA Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• Outlook resubmits wet AMD BLA for bevacizumab after FDA appeal win Eyes On Eyecare Mon, 01 Jun 2026 07:00:00 GMT
• outlook therapeutics announces resubmission of biologics license application to u.s. fda for ons-5010/lytenava™ (bevacizumab-vikg)... GlobeNewswire Mon, 01 Jun 2026 07:00:00 GMT
• gms ventures lifts outlook therapeutics (otlk) stake in $5m share deal Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• outlook therapeutics director’s firm buys $5m in common stock Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• otlk stock surges on fda lytenava application resubmission after successful appeal Stocktwits Mon, 01 Jun 2026 07:00:00 GMT
• outlook therapeutics announces registered direct offering of common stock to gms ventures – sec 8-k filing summary Minichart Sun, 31 May 2026 11:27:00 GMT
• outlook therapeutics announces registered direct equity offering The Globe and Mail Sat, 30 May 2026 22:16:00 GMT
• outlook therapeutics sells 8.54m shares in registered direct offering to gms ventures TradingView Fri, 29 May 2026 20:33:01 GMT
• these 3 stocks led wall street’s biggest gains on tuesday – here’s why Stocktwits Fri, 29 May 2026 19:50:48 GMT
• key facts: fda accepts lytenava appeal; otlk plans $5m offering TradingView Fri, 29 May 2026 07:14:09 GMT
• outlook therapeutics announces sale of about 8.5 million shares to company’s biggest stockholder ROI-NJ Fri, 29 May 2026 07:00:00 GMT
• outlook therapeutics (nasdaq: otlk) amends warrants and sells 8.54m shares Stock Titan Fri, 29 May 2026 07:00:00 GMT
• outlook therapeutics (nasdaq: otlk) sells 8,539,709 shares Stock Titan Fri, 29 May 2026 07:00:00 GMT
• outlook therapeutics announces insider-backed direct stock offering The Globe and Mail Fri, 29 May 2026 07:00:00 GMT
• outlook therapeutics raises $5m from largest shareholder by investing.com Investing.com Nigeria Fri, 29 May 2026 00:27:12 GMT
• outlook therapeutics prices $5m stock offering to fund retinal disease drug development Pluang Thu, 28 May 2026 20:46:33 GMT
• outlook therapeutics director randy thurman buys $2,145 in stock by investing.com Investing.com India Thu, 28 May 2026 18:37:35 GMT
• otlk stock rocket nearly 140%: fda's lytenava approval pushes stock on track for best week on record Yahoo Finance Thu, 28 May 2026 17:38:14 GMT
• outlook therapeutics director kurt j. hilzinger buys $176,520 in stock Investing.com UK Thu, 28 May 2026 08:06:14 GMT
• Outlook Therapeutics Announces Pricing of $5.0 Million GlobeNewswire Thu, 28 May 2026 07:00:00 GMT
• Outlook Therapeutics raises $5M from top holder, cuts warrant price to $0.5855 Stock Titan Thu, 28 May 2026 07:00:00 GMT
• OTLK Stock Rocket Nearly 140%: Lytenava Dispute Resolution With FDA Pushes Stock On Track For Best Week On Record Yahoo Finance Thu, 28 May 2026 07:00:00 GMT
• Outlook Therapeutics agrees $5.0M at-the-market registered direct offering, amends warrants TradingView Thu, 28 May 2026 07:00:00 GMT
• Outlook Therapeutics (OTLK) cuts warrant exercise price to $0.5855 Stock Titan Thu, 28 May 2026 07:00:00 GMT
• outlook therapeutics raises $5m from largest shareholder Investing.com Thu, 28 May 2026 07:00:00 GMT
• outlook therapeutics prices offering of common shares marketscreener.com Thu, 28 May 2026 07:00:00 GMT
Outlook Therapeutics, Inc(NASDAQ:OTLK) 
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, a proprietary ophthalmic formulation of bevacizumab product candidate that is in Ph...
Website: http://www.outlooktherapeutics.com
Founded: 2009
Full Time Employees: 14
Sector: Healthcare
Industry: Biotechnology